CELATOR PHARMACEUTICALS INC - 15089R102
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q2 2014
· Q1 2014
Value (USD)
Total reported value ($000)
$11.03M
QoQ value delta ($000)
+$192K
(+1.77%)
Implied price effect (QoQ)
-0.65%
Shares
Total shares
3,486,374
QoQ shares delta
+83,022
(+2.44%)
Total shares held by funds (by quarter)
Top holders (Q2 2014)
Top 25 only
Full list
Partial Q2 2014 data: 4 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CAXTON CORP | 7,121 | 2,246,469 | 5.44% |
| SABBY MANAGEMENT, LLC | 2,022 | 626,077 | 0.11% |
| Opaleye Management Inc. | 1,031 | 325,000 | 0.76% |
| VANGUARD GROUP INC | 664 | 224,367 | 0.0% |
| Alpha Cubed Investments, LLC | 95 | 32,092 | 0.04% |
| HAMILTON LANE ADVISORS LLC | 51 | 17,280 | 0.02% |
| Concept Capital Markets, LLC | 36 | 12,000 | 0.01% |
| UBS AG | 10 | 3,045 | 0.0% |
| MORGAN STANLEY | 0 | 44 | 0.0% |